Biotron Limited (ASX:BIT) shares sank 27% lower on Wednesday

The Biotron Limited (ASX:BIT) share price was smashed on Wednesday and sank 27% lower. Here's what you need to know…

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Biotron Limited (ASX: BIT) share price was a big mover on the market again on Wednesday, but unfortunately on this occasion it was in the wrong direction.

The drug development company's shares finished the day down by 27% to 16 cents.

This means that Biotron's shares have now fallen 63% since peaking at 44 cents earlier this month.

Why were Biotron's shares smashed on Wednesday?

While I suspect that profit taking from day traders has been largely to blame for its sharp decline over the last few days, there was news out of the company this morning that could have influenced proceedings.

Biotron released its quarterly report for the three months ended September 30 before the market opened. That update revealed a cash outflow from operating activities of $606,000. Which means that combined with small outflows from financing and investing activities, Biotron's cash position was reduced to $896,000 at the end of the quarter.

For the quarter to come the company expects cash outflows of $698,000 due to research and development, staff, and administration and corporate costs. This may have investors concerned that a capital raising is going to be required in the near future to fund its operations.

While I wouldn't rule out a capital raising entirely, it is unlikely to be required during the current quarter. This is because since the end of the last quarter the company has received an R&D tax incentive refund of approximately $1.1 million and also signed an options underwriting agreement with CPS Capital.

The latter means the company will receive around $4.7 million when 78.4 million options expire on November 30 with a 6 cents per share exercise price.

Based on its current outflows, these funds could keep the company going for the next couple of years.

Should you buy the dip?

While its cash position appears positive, that doesn't necessarily mean that I would be buying its shares today. I think Biotron is an exciting company due to the potential of its BIT225 drug, but there's still a long road ahead for the company before it is generating meaningful revenues.

For now, I intend to keep Biotron on my watchlist and consider relatively safer healthcare shares such as CSL Limited (ASX: CSL) and Mayne Pharma Group Ltd (ASX: MYX).

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Fallers

Disappointed man with his head on his hand looking at a falling share price his a laptop.
Share Fallers

Why 29Metals, Atlas Arteria, DroneShield, and Yancoal shares are falling today

Let's see why these shares are ending the week in the red.

Read more »

Shot of a young businesswoman looking stressed out while working in an office.
Share Fallers

Why 29Metals, CAR Group, DroneShield, and Santana Minerals shares are falling today

These shares are missing out on the good times on Thursday. But why?

Read more »

Frustrated stock trader screaming while looking at mobile phone, symbolising a falling share price.
Share Fallers

Why Imricor, Imugene, Newmont, and Pepper Money shares are falling today

These shares are having a tough time on hump day. But why?

Read more »

A man sits in despair at his computer with his hands either side of his head, staring into the screen with a pained and anguished look on his face, in a home office setting.
Share Fallers

Why Cromwell Property, Metcash, Pilbara Minerals, and Tyro shares are falling today

Let's see why these shares are under pressure on Tuesday.

Read more »

Frustrated stock trader screaming while looking at mobile phone, symbolising a falling share price.
Share Fallers

Why Block, Computershare, South32, and Strickland Metals shares are falling today

These shares are starting the week in the red. But why?

Read more »

Person with thumbs down and a red sad face poster covering the face.
Share Fallers

Why Imricor, Ora Banda, Ventia, and Vulcan shares are dropping today

These shares are ending the week in the red. But why?

Read more »

A man sits in despair at his computer with his hands either side of his head, staring into the screen with a pained and anguished look on his face, in a home office setting.
Share Fallers

Why CSL, Imricor, Jumbo, and Netwealth shares are falling today

These shares are under pressure on Thursday. But why?

Read more »

A man holds his head in his hands, despairing at the bad result he's reading on his computer.
Share Fallers

Guess which ASX 200 stock is crashing 42% on big news

Big bad news is weighing heavily on this stock today.

Read more »